Breast cancer survivor offers wisdom at Faulkner satellite center
Call 877-422-3324 today to make an appointment
Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.
Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.
Toll-Free Number866-408-DFCI (3324)
Discover the ways to give and how to get involved to support Dana-Farber.
Poet Richard Fox gains insight – and material – through cancer treatment
A family faces cancer in an unfamiliar city – with help
Choosing mastectomy or not: Studying young women's surgical choices
Jeff's targeted therapy has kept his advanced lung cancer at bay.
CIO named Dana-Farber Cancer Institute as a 2008 CIO 100
Award winner. The magazine presents the award to 100 organizations
around the world that exemplify the highest level of operational and
strategic excellence in information technology. The winners were
announced in the magazine's Aug. 15 issue.
The award recognizes Dana-Farber for its implementation of a system
to collect clinical research study data electronically. Dana-Farber
clinicians and researchers had been using a paper-based system to
compile data and generate reports, but the process was time-consuming
and there was a margin for inaccurate data input.
Dana-Farber's electronic data capture (EDC) system uses Phase
Forward's InForm™ Integrated Trial Management software to collect all
data and generate documents electronically. This allows for greater
organization and immediate sharing of data. Previously, data could take
four to eight weeks to be accessed.
"We are honored by this recognition of our work in moving to
electronic data capture for clinical trials," said Jeffrey Kessler,
Dana-Farber's chief information officer. "EDC has reduced the time to
access data from as much as eight weeks to real-time, and decreased the
time to resolve queries from weeks to hours. This translates to more
meaningful study results."
EDC was used in 2006 during a pediatric Acute Lymphoblastic Leukemia
(ALL) study, which involved 500 subjects during a five-year period in
nine centers across the globe. There were 36 unique case report forms
and 49 programmed unique edit checks, which helped ensure data
integrity; the case report form had 155 unique questions. Every patient
in the study had to complete a total of 50 forms across eight visits,
which worked out to 77,500 data points for the whole trial.
With the vast amount of information, locations and patients, paper
data would have been difficult to keep track of and would not have been
shared in a timely way. The automated system also has an edit-checking
aspect to improve accuracy, which manual records do not have the
capacity to do.
The award will be presented at The Broadmoor in Colorado Springs,
Colo., on Aug. 26 at the conclusion of the tenth annual CIO 100
Symposium and Awards Ceremony.
Dana-Farber Cancer Institute (www.dana-farber.org)
is a principal teaching affiliate of the Harvard Medical School and is
among the leading cancer research and care centers in the United States.
It is a founding member of the Dana-Farber/Harvard Cancer Center
(DF/HCC), designated a comprehensive cancer center by the National